These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4259647)

  • 1. [Therapeutic influence on the blood lipids in manifest coronary sclerosis].
    Aschenbeck G
    Rev Bras Med; 1971 Dec; 28(12):653-8. PubMed ID: 4259647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 5. [The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis].
    Caruzzo C; Carnaghi R; Enrico-Bena L; De Marco G
    Minerva Med; 1969 Nov; 60(91):4514-8. PubMed ID: 5357297
    [No Abstract]   [Full Text] [Related]  

  • 6. Rational prescribing of statins.
    Purcell H; Daly C; Sheppard M; Morrell J
    Practitioner; 2001 Nov; 245(1628):957-9, 962-3. PubMed ID: 11727350
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
    Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T
    Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of atherosclerosis in cholesterol-fed rabbits by a heparitin sulfate. Preliminary communication.
    Grossman BJ; Cifonelli JA; Ozoa AK
    Atherosclerosis; 1971; 13(1):103-9. PubMed ID: 4252017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the lipid pattern after administration of glucuronyl-glucosaminoglycan sulfate (3 GS) inpatients with with acute coronary syndromes].
    Gallone S; Mangiameli D; Vanaria F; Branca D; Lombardo D
    Boll Soc Ital Cardiol; 1975; 20(4):309-14. PubMed ID: 133704
    [No Abstract]   [Full Text] [Related]  

  • 10. Measures to reduce the serum lipid levels in coronary heart disease.
    Connor WE
    Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of feeding soya-bean oil on postheparin plasma lipolytic activity.
    Cybulska B; Szostak WB; Bialkowska M; Swiatkowska K
    Mater Med Pol; 1973; 5(4):247-9. PubMed ID: 4799526
    [No Abstract]   [Full Text] [Related]  

  • 12. Lowering cholesterol reduces mortality for heart patients with "normal" lipids.
    Harv Heart Lett; 1999 Feb; 9(6):5. PubMed ID: 10028898
    [No Abstract]   [Full Text] [Related]  

  • 13. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statin therapy is a basic treatment for coronary heart disease].
    Gurevich MA
    Klin Med (Mosk); 2003; 81(12):60-2. PubMed ID: 14971160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of ethyl-chlorphenoxy-isobutyrate on serum lipid values in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diezendy S; Erdélyi G
    Orv Hetil; 1966 May; 107(22):1020-2. PubMed ID: 5935787
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.